Switch to:
More From Other Websites
Eli Lilly & Co. Earnings Analysis: By the Numbers Jul 29 2015
Be careful not to raise false hopes over Alzheimer's Jul 28 2015
Market Response to Biogen’s and Eli Lilly’s Alzheimer’s Drugs Jul 28 2015
Why Pharmaceutical Eli Lilly & Co. Warrants Attention from Investors Right Now - Stocks in the News Jul 28 2015
Eli Lilly’s Solanezumab: A Possible Cure for Alzheimer’s? Jul 28 2015
Cramer's shopping list for a pullback Jul 27 2015
Teva to Buy Allergan Generics for $40.5 Billion Jul 27 2015
Lilly continues test of HDL cholesterol drug, on panel's advice Jul 27 2015
Lilly Provides Update on Evacetrapib Phase 3 Trial Jul 27 2015
8:04 am Eli Lilly Provides Update on Evacetrapib Phase 3 Trial; co has accepted the recommendation... Jul 27 2015
Lilly Provides Update on Evacetrapib Phase 3 Trial Jul 27 2015
AbbVie: Beware the Biosimilars? Jul 24 2015
3 Big-Cap Drugmakers Who Beat Q2 Earnings Estimates Jul 23 2015
Lilly (Eli) (LLY) Earnings Report: Q2 2015 Conference Call Transcript Jul 23 2015
Edited Transcript of LLY earnings conference call or presentation 23-Jul-15 1:00pm GMT Jul 23 2015
Analyst's Key Takeaways From Eli Lilly, Bristol-Myer Squibb's Latest Conference Calls Jul 23 2015
Eli Lilly, Biogen Present Data at Alzheimer's Association - Analyst Blog Jul 23 2015
[$$] Lilly Posts Higher Sales, Boosts Outlook Jul 23 2015
Eli Lilly Beats on 2Q Earnings by Wide Margin, Ups View - Analyst Blog Jul 23 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK